Open AccessIntermediate stage hepatocellular carcinoma: Comparison of the value of inflammation-based scores in predicting progression-free survival of patients receiving transarterial chemoembolization
Author(s) -
Ying Li,
Menting Shi,
Shuanggang Chen,
Weiqi Wan,
Lujun Shen,
Binyan Shen,
Han Qi,
Fei Cao,
Ying Wu,
Tao Huang,
Guanjian Chen,
Jinqing Mo,
Dongdong Ye,
Yinqi Zhang,
Ziqing Feng,
Weijun Fan
Publication year - 2021
Publication title -
journal of cancer research and therapeutics/journal of cancer research and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 39
eISSN - 0973-1482
pISSN - 1998-4138
DOI - 10.4103/jcrt.jcrt_29_21
Subject(s) - medicine , hepatocellular carcinoma , stage (stratigraphy) , neutrophil to lymphocyte ratio , oncology , multivariate analysis , proportional hazards model , receiver operating characteristic , inflammation , gastroenterology , lymphocyte , paleontology , biology
The identification of inflammation-related prognostic heterogeneity in intermediate-stage hepatocellular carcinoma (HCC) can reveal more effective first-line treatments. Our study aimed to compare the intermediate-stage HCC patients' different inflammation-based scores in predicting their progression-free survival (PFS) after transarterial chemoembolization (TACE).